MarketCap
Facebook
X
TelegramQuarterly report 2025-Q1
added 05-23-2026
Renalytix AI plc ROE Ratio 2011-2026 | RNLX
Annual ROE Ratio Renalytix AI plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 425.97 | -654.61 | -147.93 | -49.45 | -61.87 | -494.69 | 113.94 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 425.97 | -654.61 | -124.09 |
Quarterly ROE Ratio Renalytix AI plc
| 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 899.13 | 964.01 | 1575.34 | 1401.79 | 603.23 | 433.14 | -247.88 | -395.8 | -378.87 | -294.77 | -248.19 | -149.71 | -110.72 | -87.77 | -79.66 | -92.07 | -575.8 | -451.35 | -61.87 | - | - | - | -494.69 | - | - | - | 113.94 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1575.34 | -575.8 | 110.54 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 203.78 | -0.37 % | $ 22.6 B | USA |
 |
Celcuity
CELC
|
-176.06 | $ 88.24 | -4.7 % | $ 4.13 B | USA |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-227.33 | $ 4.88 | 8.44 % | $ 6.49 M | USA |
 |
Fulgent Genetics
FLGT
|
-5.44 | $ 18.93 | 2.32 % | $ 583 M | USA |
 |
Castle Biosciences
CSTL
|
-5.13 | $ 21.08 | - | $ 611 M | USA |
 |
Aspira Women's Health
AWH
|
0.18 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
89.3 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
ICON Public Limited Company
ICLR
|
2.49 | $ 144.59 | -4.76 % | $ 11.3 B |  Irlanda |
 |
Illumina
ILMN
|
31.22 | $ 162.47 | 1.52 % | $ 25.2 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
Guardant Health
GH
|
419.21 | $ 130.7 | 0.45 % | $ 16.4 B | USA |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 23.46 | 3.12 % | $ 1.25 B | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
120.45 | - | - | $ 9.42 M |  Israel |
 |
Interpace Biosciences
IDXG
|
109.89 | $ 1.76 | 1.32 % | $ 7.79 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-656.53 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-147.83 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 100.24 | 0.26 % | $ 6.77 B | USA |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 186.29 | -1.88 % | $ 9.23 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
Pacific Biosciences of California
PACB
|
-10214.99 | $ 1.37 | - | $ 411 M | USA |
 |
Medpace Holdings
MEDP
|
98.27 | $ 465.73 | -0.23 % | $ 13.4 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | USA |
 |
Mettler-Toledo International
MTD
|
-3677.41 | $ 1 133.03 | -2.58 % | $ 23.4 B |  Schweiz |
 |
NeoGenomics
NEO
|
-12.91 | $ 11.28 | -1.4 % | $ 1.44 B | USA |
 |
Myriad Genetics
MYGN
|
-99.46 | $ 4.43 | -2.42 % | $ 410 M | USA |
 |
National Research Corporation
NRC
|
82.92 | $ 21.28 | 7.75 % | $ 476 M | USA |
 |
Natera
NTRA
|
-12.16 | $ 216.5 | -2.84 % | $ 29.6 B | USA |
 |
Personalis
PSNL
|
-31.12 | $ 9.61 | -1.44 % | $ 858 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
8.16 | $ 25.67 | -3.13 % | $ 24.3 B |  Niderland |
 |
Senseonics Holdings
SENS
|
-113.19 | $ 7.3 | -1.75 % | $ 305 M | USA |
 |
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
4.64 | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
-121.14 | $ 2.02 | -1.51 % | $ 4.64 M | USA |
 |
Twist Bioscience Corporation
TWST
|
-16.42 | $ 67.77 | -3.27 % | $ 4.05 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 268.63 | -0.96 % | $ 22.4 B | USA |
 |
Thermo Fisher Scientific
TMO
|
12.55 | $ 482.04 | -2.43 % | $ 182 B | USA |
 |
Trinity Biotech plc
TRIB
|
88.73 | $ 0.69 | 3.51 % | $ 248 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 9.17 | -1.29 % | $ 1.99 B | USA |
 |
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | USA |